Microbiomes in pancreatic cancer can be an accomplice or a weapon

Xiaoyu Guo,Pan Wang,Yuan Li,Yawei Chang,Xiaobing Wang
DOI: https://doi.org/10.1016/j.critrevonc.2024.104262
IF: 6.625
2024-01-10
Critical Reviews in Oncology/Hematology
Abstract:Recently, several investigations have linked the microbiome to pancreatic cancer progression. It is critical to reveal the role of different microbiomes in the occurrence, development, and treatment of pancreatic cancer. The current review summarizes the various microbiota types in pancreatic cancer while updating and supplementing the mechanisms of the representative gut, pancreatic, and oral microbiota, and their metabolites during its pathogenesis and therapeutic intervention. Several novel strategies have been introduced based on the tumor-associated microbiome to optimize the early diagnosis and prognosis of pancreatic cancer. The pros and cons involving different microbiomes in treating pancreatic cancer are discussed. The microbiome-related clinical trials for pancreatic cancer theranostics are outlined. This convergence of cutting-edge knowledge will provide feasible ideas for developing innovative therapies against pancreatic cancer.
oncology,hematology
What problem does this paper attempt to address?